Media Database
>
Brian Gormley

Brian Gormley

Reporter at WSJ Pro: Venture Capital

Contact this person
Email address
b*****@*******.comGet email address
Influence score
64
Phone
(XXX) XXX-XXXX Get mobile number
Location
United States
Languages
  • English
Covering topics
  • Finance & Banking Services

View more media outlets and journalists by signing up to Prowly

View latest data and reach out all from one place
Sign up for free

Recent Articles

wsj.com

Bruce Booth Has Seen It All in Biotech Venture Capital

Bruce Booth Has Seen It All in Biotech Venture Capital
wsj.com

Bruce Booth Has Seen It All in Biotech Venture Capital

Bruce Booth Has Seen It All in Biotech Venture Capital
wsj.com

Bruce Booth Has Seen It All in Biotech Venture Capital

Bruce Booth Has Seen It All in Biotech Venture Capital
wsj.com

Is the Drought in Life-Sciences IPOs Over? Two Startups Will Test D...

Is the Drought in Life-Sciences IPOs Over? Two Startups Will Test Demand
wsj.com

Is the Drought in Life-Sciences IPOs Over? Two Startups Will Test D...

Is the Drought in Life-Sciences IPOs Over? Two Startups Will Test Demand
wsj.com

BillionToOne, Evommune Shares Climb in IPOs

BillionToOne, Evommune Shares Climb in IPOs
wsj.com

Is the Drought in Life-Sciences IPOs Over? Two Startups Will Test D...

Is the Drought in Life-Sciences IPOs Over? Two Startups Will Test Demand
wsj.com

Is the Drought in Life-Sciences IPOs Over? Two Startups Will Test D...

Is the Drought in Life-Sciences IPOs Over? Two Startups Will Test Demand
wsj.com

Is the Drought in Life-Sciences IPOs Over? Two Startups Will Test D...

Is the Drought in Life-Sciences IPOs Over? Two Startups Will Test Demand
wsj.com

Is the Drought in Life-Sciences IPOs Over? Two Startups Will Test D...

Is the Drought in Life-Sciences IPOs Over? Two Startups Will Test Demand
wsj.com

Is the Drought in Life-Sciences IPOs Over? Two Startups Will Test D...

Is the Drought in Life-Sciences IPOs Over? Two Startups Will Test Demand